RYE MEDICAL CENTRE — All Prescriptions & Medications — Page 2
Practice Code: G81051 | RYE, TN31 7SQ
Showing results 51-100 of 639
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Gabapentin | 1,097 | 108.8K | £5.5K | +9.9% ▲ |
| Propranolol hydrochloride | 1,074 | 62.5K | £1.8K | +0.6% vs avg |
| Fluoxetine hydrochloride | 1,067 | 37.5K | £2.7K | +5.2% ▲ |
| Pregabalin | 1,066 | 62.1K | £3.4K | -15.1% ▼ |
| Glucose blood testing reagents | 1,063 | 80.9K | £11.6K | +34.7% ▲ |
| Progesterone | 1,063 | 65.0K | £12.2K | +154.0% ▲ |
| Duloxetine hydrochloride | 1,047 | 26.4K | £2.1K | +64.7% ▲ |
| Esomeprazole | 1,034 | 32.9K | £3.7K | +155.5% ▲ |
| Macrogol 3350 | 998 | 39.6K | £6.8K | +6.4% ▲ |
| Warfarin sodium | 978 | 33.2K | £1.2K | +107.4% ▲ |
| Semaglutide | 967 | 12.4K | £70.4K | +301.6% ▲ |
| Doxycycline hyclate | 947 | 10.1K | £1.0K | +84.7% ▲ |
| 865 | 129.4K | £4.1K | +82.3% ▲ | |
| Alginic acid compound preparations | 851 | 391.6K | £4.8K | +45.3% ▲ |
| Nitrofurantoin | 849 | 15.3K | £3.7K | +77.9% ▲ |
| Finasteride | 848 | 21.2K | £799 | +29.5% ▲ |
| Sildenafil (Erectile Dysfunction) | 826 | 7,647 | £1.2K | +63.9% ▲ |
| Mirabegron | 813 | 21.6K | £19.1K | +102.4% ▲ |
| Mometasone furoate | 813 | 822 | £7.4K | +102.5% ▲ |
| Latanoprost | 804 | 16.7K | £4.9K | +65.6% ▲ |
| Diltiazem hydrochloride | 785 | 23.8K | £4.8K | +155.6% ▲ |
| Escitalopram | 771 | 21.5K | £2.0K | +170.9% ▲ |
| Buprenorphine | 770 | 4,524 | £21.2K | +110.2% ▲ |
| Cetirizine hydrochloride | 736 | 28.9K | £1.2K | +47.3% ▲ |
| Loratadine | 733 | 22.4K | £493 | +250.8% ▲ |
| Rivaroxaban | 724 | 19.5K | £12.5K | +18.3% ▲ |
| Carbocisteine | 718 | 84.3K | £2.0K | +34.5% ▲ |
| Spironolactone | 701 | 16.3K | £2.0K | +30.0% ▲ |
| Isosorbide mononitrate | 695 | 18.0K | £3.6K | +5.2% ▲ |
| 693 | 12.5K | £6.4K | +4.3% ▲ | |
| Famotidine | 677 | 19.3K | £12.7K | +38.7% ▲ |
| Venlafaxine | 660 | 21.1K | £5.0K | -21.9% ▼ |
| Alogliptin | 650 | 14.6K | £12.6K | +156.3% ▲ |
| Irbesartan | 649 | 18.4K | £728 | +166.4% ▲ |
| Budesonide | 618 | 1,035 | £18.1K | +14.0% ▲ |
| Hydrocortisone | 611 | 25.4K | £3.8K | +36.3% ▲ |
| Fluticasone propionate (Inhalation) | 600 | 638 | £16.6K | +55.1% ▲ |
| Montelukast | 599 | 14.6K | £773 | -12.5% ▼ |
| Solifenacin | 596 | 15.2K | £587 | +24.9% ▲ |
| Fexofenadine hydrochloride | 578 | 19.2K | £871 | -32.0% ▼ |
| 576 | 281.4K | £4.6K | -41.5% ▼ | |
| Codeine phosphate | 574 | 36.9K | £1.3K | -20.1% ▼ |
| Lisinopril | 568 | 19.0K | £454 | -48.2% ▼ |
| Atenolol | 545 | 13.6K | £312 | -9.6% ▼ |
| Quetiapine | 541 | 21.9K | £11.5K | -13.1% ▼ |
| Insulin degludec | 534 | 3,000 | £33.6K | +385.9% ▲ |
| Umeclidinium bromide/vilanterol | 533 | 533 | £15.9K | +173.3% ▲ |
| Methotrexate | 531 | 11.2K | £3.2K | +63.1% ▲ |
| Sumatriptan succinate | 527 | 5,848 | £2.8K | +48.8% ▲ |
| Flucloxacillin sodium | 526 | 22.2K | £1.3K | +17.0% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.